GHRL and Hepatic fibrosis: For instance, ghrelin administration therapy dramatically decreased TGF-β1 and p-Smad3 protein expression in a mouse model of hepatic fibrosis, as well as reduced extracellular matrix formation and myofibroblast accumulation (Ref.